Expect More Than Standard Antitrust Scrutiny For ChemChina/Syngenta Deal

State-owned ChemChina has officially made an aggressive $43 billion bid for Swiss seeds and pesticides company Syngenta AG (ADR) SYT 0.45%.

Following confirmation of the deal, Benzinga had the chance to speak with Chris Pultz of the Kellner Merger Fund regarding the possibility that the deal could face regulatory threats or delays and where a completed deal leaves Monsanto Company MON 3.52%.

Speaking With Chris Pultz

When Benzinga asked about potential regulatory hurdles, Pultz said the deal could face some political pushback, but not from an antitrust perspective.

“This deal needs to be reviewed by the Committee on Foreign Investments in the United States,” Pultz explained. “You have a Chinese state-owned company that is buying something that, even though it’s not intellectual property, it is important to the food chain. So the debate over whether it will be construed as being a ‘national interest’ here could create some political backlash.”

He added…

Click here to continue reading

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common SenseI don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!